A new, powerful Citizen Portal experience is ready. Switch now

Committee hears competing views on HB 3,088, a bill targeting anti‑steering, gag and most‑favored‑nation contract clauses

March 04, 2026 | 2026 Legislature MO, Missouri


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Committee hears competing views on HB 3,088, a bill targeting anti‑steering, gag and most‑favored‑nation contract clauses
Representative Dane Deal introduced House Bill 3,088 as an anti‑consolidation, pro‑consumer measure aimed at contract clauses he said can prevent price‑shopping and lock patients into higher‑cost providers. Deal described the bill's targeted clauses — anti‑steering, anti‑tiering, gag clauses and most‑favored‑nation provisions — and said the intent is to preserve local options and protect rural hospital access.

Supporters described concrete examples. Adam Meyer (Cicero Action) and Hampton Williams (Missouri Insurance Coalition) explained how anti‑steering and anti‑tiering clauses can prevent insurers from offering tiered cost‑sharing or apps that push patients to lower‑cost providers; they argued the measures would promote competition and bend the health‑care cost curve. James Harris (FGA Action) and Josh Haines (Elevance Health) added that right‑to‑shop tools and cash‑back incentives can be blocked by restrictive contract terms and urged preemptive state action.

Opponents, led by Eric Vanderweerd of the Missouri Hospital Association, said many rural hospitals operate on margins near break‑even and rely on negotiated contract terms to ensure predictable revenue and network adequacy. Vanderweerd urged that the bill be carefully redrafted to avoid unintended consequences and suggested allowing full contract renegotiation rather than striking terms unilaterally.

Committee members asked detailed questions about market effects, network adequacy, the 340B drug‑pricing program, and whether the bill would advantage insurance carriers at hospitals' expense. Supporters said the bill mirrors actions taken in other states and is intended to protect patients and payers alike; opponents said the drafting lacked guardrails and could destabilize provider finances. The committee concluded the hearing without final action.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee